[1. S. Adams, D. Heckard, J. Hassell and L. Uphouse, Factors influencing fluoxetine-induced sexual dysfunction in female rats, Behav. Brain Res. 235 (2012) 73-81; https://doi.org/10.1016/j.bbr.2012.07.02910.1016/j.bbr.2012.07.029343267822835821]Search in Google Scholar
[2. M. Afkhami-Ardekani and H. Sedghi, Effect of fluoxetine on weight reduction in obese patients, Indian J. Clin. Biochem. 20 (2005) 135-138.10.1007/BF02893059345417523105511]Search in Google Scholar
[3. S. R. Blumenthal, V. M. Castro, C. C. Clements, H. R. Rosenfield, S. N. Murphy, M. Fava, J. B. Weilburg, J. L. Erb, S. E. Churchill, I. S. Kohane, J. W. Smoller and R. H. Perlis, An electronic health records study of long-term weight gain following antidepressant use, JAMA Psychiatry 71 (2014) 889-896; https://doi.org/10.1001/jamapsychiatry.2014.41410.1001/jamapsychiatry.2014.41424898363]Search in Google Scholar
[4. J. P. Domecq, G. Prutsky, A. Leppin, M. B. Sonbol, O. Altayar, C. Undavalli, Z. Wang, T. Elraiyah, J. P. Brito, K. F. Mauck, M. H. Lababidi, L. J Prokop, N. Asi, J. Wei, S. Fidahussein, V. M. Montori and M. H. Murad, Clinical review: Drugs commonly associated with weight change: a systematic review and meta-analysis, J. Clin. Endocrinol. Metab. 100 (2015) 363-370; https://doi.org/10.1210/jc.2014-342110.1210/jc.2014-3421539350925590213]Search in Google Scholar
[5. C. S. Hudak and H. S. Sul, Pref-1, a gatekeeper of adipogenesis, Front. Endocrinol. 4 (2013) 1-6; https://doi.org/10.3389/fendo.2013.0007910.3389/fendo.2013.00079369971423840193]Search in Google Scholar
[6. S. Caccia, M. Cappi, C. Fracasso and S. Garattini, Influence of dose and route of administration on the kinetics of fluoxetine and its metabolite norfluoxetine in the rat, Psychopharmacology (Berlin) 100 (1990) 509-514.10.1007/BF022440042320712]Search in Google Scholar
[7. N. W. Jacobsen, C. H. Hansen, C. Nellemann, B. Styrishave and B. Halling-Sørensen, Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay, Toxicol. in Vitro 29 (2015) 1729-1735; https://doi.org/10.1016/j.tiv.2015.07.00510.1016/j.tiv.2015.07.00526162595]Search in Google Scholar
[8. B. K. Sun, J. H. Kim, J. S. Choi, S. J. Hwang and J. H. Sung, Fluoxetine decreases the proliferation and adipogenic differentiation of human adipose-derived stem cells, Int. J. Mol. Sci. 16 (2015) 16655-16668; https://doi.org/10.3390/ijms16071665510.3390/ijms160716655451997126204837]Search in Google Scholar
[9. M. Kolcsár, Z. Gáll, I. L. Bíró, L. I. Bába, A. Imre, M. T. Dogaru and O. Martha, Fluoxetine influence on body weight, serum adiponectin level and adipose tissue triglycerides levels in rats, Farmacia 6 (2016) 599-604.]Search in Google Scholar
[10. A. K. Stunes, J. E. Reseland, O. Hauso, M. Kidd, K. Tommeras, H. L. Waldum, U. Syversen and B. I. Gustafsson, Adipocytes express a functional system for serotonin synthesis, reuptake and receptor activation, Diabetes Obes. Metab. 13 (2011) 551-558; https://doi.org/10.1111/j.1463-1326.2011.01378.x10.1111/j.1463-1326.2011.01378.x21320265]Search in Google Scholar
[11. S. Grès, S. Canteiro, J. Mercader and C. Carpéné, Oxidation of high doses of serotonin favors lipid accumulation in mouse and human fat cells, Mol. Nutr. Food Res. 57 (2013) 1089-1099; https://doi.org/10.1002/mnfr.20120068110.1002/mnfr.20120068123390020]Search in Google Scholar
[12. S. Grès, S. Gomez-Zorita, A Gomez-Ruiz and C. Carpene, 5-Hydroxytryptamine actions in adipocytes: involvement of monoamine oxidase-dependent oxidation and subsequent PPARγ activation, J. Neural. Transm. (Vienna) 120 (2013) 919-926; https://doi.org/10.1007/s00702-012-0959-810.1007/s00702-012-0959-823271029]Search in Google Scholar